Papers
47
Total Citations
1,928
H-Index
24
About
Ashwin Sridhar is a leading urological surgeon and researcher whose work sits at the intersection of robotic surgery, surgical training, and oncological outcomes in bladder and prostate cancer. Based primarily at University College London, Sridhar has made seminal contributions to the advancement of robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion, demonstrating through rigorous clinical investigation — including a landmark 2022 randomized controlled trial garnering over 320 citations — that fully intracorporeal robotic approaches significantly reduce morbidity compared to open surgery. His early technical work describing the intracorporeal pyramid neobladder established foundational surgical techniques now adopted internationally. Equally influential is his sustained focus on robotic surgical education: his widely cited reviews on training frameworks, learning curves, and objective skills assessment have shaped how institutions credentialize robotic surgeons. His pioneering work integrating artificial intelligence into surgical training assessment, including a notable Delphi consensus on ethical implications, reflects his forward-thinking approach to patient safety. With over 900 combined citations across his top publications, Sridhar's research has meaningfully elevated standards in both minimally invasive oncological surgery and the rigorous, evidence-based training of the next generation of robotic surgeons.
Research Focus
Key Achievements
Top Papers
- 1
- 2Training in Robotic Surgery—an Overview205 citations · 2017
- 3
- 4
- 5
- 6
- 7Learning Curves for Robotic Surgery: a Review of the Recent Literature71 citations · 2017
- 8Robot‐assisted intracorporeal pyramid neobladder70 citations · 2015
- 9
- 10